upstream kinase pdk2 (Proteintech)
Proteintech is a verified supplier 
93
Structured Review
Proteintech
upstream kinase pdk2
Upstream Kinase Pdk2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 26 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/upstream+kinase+pdk2/PDK2+Antibody/10__1007_slash_s13167___025___00428___1-77-52-63
Average 93 stars, based on 26 article reviews
Upstream Kinase Pdk2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 26 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/upstream+kinase+pdk2/PDK2+Antibody/10__1007_slash_s13167___025___00428___1-77-52-63
Average 93 stars, based on 26 article reviews
upstream kinase pdk2 - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Immunohistochemistry:Article Title: Glioma angiogenesis phosphoproteome landscape and biomarker sets identified with phenome-centered multiomics toward 3P medical approaches Article Snippet: Protein phosphorylation is an important molecular event in tumor angiogenesis that is a canonical hallmark in glioma.. We hypothesize that the phosphoproteome and phosphorylation-mediated signaling networks are significantly different in glioma neovascular tissues compared to controls, which aimed to identify glioma angiogenesis phosphoproteomic landscape, phosphorylation-mediated signaling pathways, kinase-substrate networks, and phosphorylation biomarkers with integration of phosphoprotein data and multiomics data, for deep understanding of molecular mechanisms of glioma angiogenesis, discovery of effective antiangiogenesis therapeutic targets, and establishment of angiogenesis-related phosphorylation biomarker signature for patient stratification, early-stage diagnosis, and effective prognostic assessment, in the framework of predictive, preventive, and personalized medicine (PPPM, 3PM) approaches.. This study used laser capture microdissection to isolate neovascular tissues from gliomas, followed by quantitative phosphoproteomics analysis, which identified 195 differentially phosphorylated proteins (DPPs) with 635 phosphosites and 58 hub DPPs. Phospho-proteomics:Article Title: Glioma angiogenesis phosphoproteome landscape and biomarker sets identified with phenome-centered multiomics toward 3P medical approaches Article Snippet: Protein phosphorylation is an important molecular event in tumor angiogenesis that is a canonical hallmark in glioma.. We hypothesize that the phosphoproteome and phosphorylation-mediated signaling networks are significantly different in glioma neovascular tissues compared to controls, which aimed to identify glioma angiogenesis phosphoproteomic landscape, phosphorylation-mediated signaling pathways, kinase-substrate networks, and phosphorylation biomarkers with integration of phosphoprotein data and multiomics data, for deep understanding of molecular mechanisms of glioma angiogenesis, discovery of effective antiangiogenesis therapeutic targets, and establishment of angiogenesis-related phosphorylation biomarker signature for patient stratification, early-stage diagnosis, and effective prognostic assessment, in the framework of predictive, preventive, and personalized medicine (PPPM, 3PM) approaches.. This study used laser capture microdissection to isolate neovascular tissues from gliomas, followed by quantitative phosphoproteomics analysis, which identified 195 differentially phosphorylated proteins (DPPs) with 635 phosphosites and 58 hub DPPs. |